3-[4-(4-methylpiperazin-1-yl)anilino]piperidine-2,6-dione is a high-purity E3 ligase ligand widely utilized in PROTAC (Proteolysis Targeting Chimera) research and drug discovery. As an analog of thalidomide, this compound specifically binds to the cereblon (CRBN) E3 ubiquitin ligase, serving as a key building block for constructing targeted protein degraders. Its unique structure facilitates linker attachment and enables the rational design of new PROTACs aimed at selective protein degradation. This ligand is indispensable for researchers developing novel CRBN-based PROTACs to target disease-relevant proteins for therapeutic intervention.
Structure of 2259851-17-5
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
3-[4-(4-methylpiperazin-1-yl)anilino]piperidine-2,6-dione is a small-molecule ligand structurally related to thalidomide analogs, designed as a potent recruiter of the E3 ubiquitin ligase Cereblon (CRBN) in targeted protein degradation research. Its distinct 4-methylpiperazine modification enhances binding properties and pharmacokinetic profiles, making it a valuable scaffold in the development of heterobifunctional PROTAC (Proteolysis Targeting Chimeras) molecules.
Mechanism
This compound functions as a CRBN E3 ligase ligand that selectively binds to the Cereblon component of the CUL4A-DDB1 E3 ubiquitin ligase complex. Upon conjugation to a ligand targeting a protein of interest, it facilitates the proximity-driven ubiquitination and subsequent proteasomal degradation of target proteins. The anilino and piperazinyl substitutions optimize E3 ligase recruitment and linker attachment, which are critical for PROTAC design and efficacy.
Applications
3-[4-(4-methylpiperazin-1-yl)anilino]piperidine-2,6-dione is widely utilized in the design and synthesis of CRBN-based PROTACs for targeted protein degradation applications in drug discovery and biomedical research. Key applications include:
• Serving as an essential E3 ligase ligand in the construction of new PROTAC degraders.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.